MiroBio
MiroBio is a clinical-stage biotech company harnessing the natural 'brakes' of the immune system to control the symptoms of auto-immune diseases. The company was acquired by Gilead Sciences in 2022.
- What
- Life Sciences
- When
- Apr 2019
- CEO
- Eliot Charles (Chair)
- Status
- Private
- Investment
- Exited